MS-500 exam dumps are provided in VCE Test Engine

MS-500 practice questions are ready by MS-500 Certified Specialists. Most individuals obtained confused that presently there is many MS-500 practice questions supplier. Choosing the latest, legitimate, and up in order to date Microsoft 365 Security Administration test prep is an extremely hard job. This issue offers been solved simply by simply by giving days up-to-date, latest and legitimate MS-500 VCE with practice questions for exercise test, that functions great in actual MS-500 exam.

Exam Code: MS-500 Practice exam 2023 by team
MS-500 Microsoft 365 Security Administration

Exam Number : MS-500

Exam Name : Microsoft 365 Security Administration

In this course you will learn how to secure user access to your organization’s resources. The course covers user password protection, multi-factor authentication, how to enable Azure Identity Protection, how to setup and use Azure AD Connect, and introduces you to conditional access in Microsoft 365. You will learn about threat protection technologies that help protect your Microsoft 365 environment. Specifically, you will learn about threat vectors and Microsoft’s security solutions to mitigate threats. You will learn about Secure Score, Exchange Online protection, Azure Advanced Threat Protection, Windows Defender Advanced Threat Protection, and threat management. In the course you will learn about information protection technologies that help secure your Microsoft 365 environment. The course discusses information rights managed content, message encryption, as well as labels, policies and rules that support data loss prevention and information protection. Lastly, you will learn about archiving and retention in Microsoft 365 as well as data governance and how to conduct content searches and investigations. This course covers data retention policies and tags, in-place records management for SharePoint, email retention, and how to conduct content searches that support eDiscovery investigations.

Learners should start this course already having the following skills:

Basic conceptual understanding of Microsoft Azure.

Experience with Windows 10 devices.

Experience with Office 365.

Basic understanding of authorization and authentication.

Basic understanding of computer networks.

Working knowledge of managing mobile devices.

Course outline

Module 1: User and Group Management

This module explains how to manage user accounts and groups in Microsoft 365. It introduces you to the Zero Trust concept as well as authentication. The module sets the foundation for the remainder of the course.


Identity and Access Management concepts

The Zero Trust model

Plan your identity and authentication solution

User accounts and roles

Password Management

Lab : Initialize your tenant - users and groups

Set up your Microsoft 365 tenant

Manage users and groups

Lab : Password management

Configure Self-service password reset (SSPR) for user accounts in Azure AD

Deploy Azure AD Smart Lockout

After completing this module, students will be able to:

Create and manage user accounts.

Describe and use Microsoft 365 admin roles.

Plan for password policies and authentication.

Describe the concepts of Zero Trust security.

Explain the Zero Trust model.

Module 2: Identity Synchronization and Protection

This module explains concepts related to synchronizing identities for Microsoft 365. Specifically, it focuses on Azure AD Connect and managing directory synchronization to ensure the right people are connecting to your Microsoft 365 system.


Plan directory synchronization

Configure and manage synchronized identities

Azure AD Identity Protection

Lab : Implement Identity Synchronization

Set up your organization for identity synchronization

After completing this module, students will be able to:

Explain directory synchronization.

Plan directory synchronization.

Describe and use Azure AD Connect.

Configure Azure AD Connect Prerequisites.

Manage users and groups with directory synchronization.

Describe Active Directory federation.

Enable Azure Identity Protection

Module 3: Identity and Access Management

This module explains conditional access for Microsoft 365 and how it can be used to control access to resources in your organization. The module also explains Role Based Access Control (RBAC) and solutions for external access. We discuss identity governance as a concept and its components.


Application Management

Identity Governance

Manage device access

Role Based Access Control (RBAC)

Solutions for external access

Privileged Identity Management

Lab : Use Conditional Access to enable MFA

MFA Authentication Pilot (require MFA for specific apps)

MFA Conditional Access (complete an MFA roll out)

Lab : Configure Privileged Identity Management

Manage Azure resources

Assign directory roles

Activate and deactivate PIM roles

Directory roles

PIM resource workflows

View audit history for Azure AD roles in PIM

After completing this module, students will be able to:

Describe the concept of conditional access.

Describe and use conditional access policies.

Plan for device compliance.

Configure conditional users and groups.

Configure role based access control

Describe the concepts of identity governance

Configure and use Privileged Identity Management

Module 4: Security in Microsoft 365

This module explains the various cyber-attack threats that exist. It then introduces you to the Microsoft solutions used to mitigate those threats. The module finishes with an explanation of Microsoft Secure Score and how it can be used to evaluate and report your organizations security posture.


Threat vectors and data breaches

Security strategy and principles

Microsoft security solutions

Secure Score

Lab : Use Microsoft Secure Score

Improve your secure score in the Microsoft 365 Security Center

After completing this module, students will be able to:

Describe several techniques attackers use to compromise user accounts through email.

Describe techniques attackers use to gain control over resources.

List the types of threats that can be avoided by using EOP and Microsoft Defender for Office 365.

Describe the benefits of Secure Score and what kind of services can be analyzed.

Describe how to use Secure Score to identify gaps in your current Microsoft 365 security posture.

Module 5: Threat Protection

This module explains the various threat protection technologies and services available for Microsoft 365. The module covers message protection through Exchange Online Protection, Microsoft Defender for Identity and Microsoft Defender for Endpoint.


Exchange Online Protection (EOP)

Microsoft Defender for Office 365

Manage Safe Attachments

Manage Safe Links

Microsoft Defender for Identity

Microsoft Defender for Endpoint

Lab : Manage Microsoft 365 Security Services

Implement Microsoft Defender Policies

After completing this module, students will be able to:

Describe the anti-malware pipeline as email is analyzed by Exchange Online Protection.

Describe how Safe Attachments is used to block zero-day malware in email attachments and documents.

Describe how Safe Links protect users from malicious URLs embedded in email and documents that point

Configure Microsoft Defender for Identity.

Configure Microsoft Defender for Endpoint.

Module 6: Threat Management

This module explains Microsoft Threat Management which provides you with the tools to evaluate and address cyber threats and formulate responses. You will learn how to use the Security dashboard and Azure Sentinel for Microsoft 365.


Security dashboard

Threat investigation and response

Azure Sentinel

Advanced Threat Analytics

Lab : Using Attack Simulator

Conduct a simulated Spear phishing attack

Conduct simulated password attacks

After completing this module, students will be able to:

Describe how Threat Explorer can be used to investigate threats and help to protect your tenant.

Describe how the Security Dashboard gives C-level executives insight into top risks and trends.

Describe what Advanced Thread Analytics (ATA) is and what requirements are needed to deploy it.

Configure Advanced Threat Analytics.

Use the attack simulator in Microsoft 365.

Describe how Azure Sentinel can used for Microsoft 365.

Module 7: Microsoft Cloud Application Security

This module focuses on cloud application security in Microsoft 365. The module will explain cloud discovery, app connectors, policies, and alerts. You will learn how these features work to secure you cloud applications.


Deploy Cloud Application Security

Use cloud application security information

After completing this module, students will be able to:

Describe Cloud App Security.

Explain how to deploy Cloud App Security.

Control your Cloud Apps with Policies.

Use the Cloud App Catalog.

Use the Cloud Discovery dashboard.

Manage cloud app permissions.

Module 8: Mobility

This module focuses on securing mobile devices and applications. You will learn about Mobile Device Management and how it works with Microsoft Intune. You will also learn about how Intune and Azure AD can be used to secure mobile applications.


Mobile Application Management (MAM)

Mobile Device Management (MDM)

Deploy mobile device services

Enroll devices to Mobile Device Management

Lab : Device Management

Enable Device Management

Configure Azure AD for Intune

Create compliance and conditional access policies

After completing this module, students will be able to:

Describe mobile application considerations.

Manage devices with MDM.

Configure Domains for MDM.

Manage Device Security Policies.

Enroll devices to MDM.

Configure a Device Enrollment Manager Role.

Module 9: Information Protection and Governance

This module focuses on data loss prevention in Microsoft 365. You will learn about how to create policies, edit rules, and customize user notifications to protect your data.


Information protection concepts

Governance and Records Management

Sensitivity labels

Archiving in Microsoft 365

Retention in Microsoft 365

Retention policies in the Microsoft 365 Compliance Center

Archiving and retention in Exchange

In-place records management in SharePoint

Lab : Archiving and Retention

Initialize compliance

Configure retention tags and policies

After completing this module, students will be able to:

Configure sensitivity labels.

Configure archiving and retention in Microsoft 365.

Plan and configure Records Management

Module 10: Rights Management and Encryption

This module explains information rights management in Exchange and SharePoint. The module also describes encryption technologies used to secure messages.


Information Rights Management (IRM)

Secure Multipurpose Internet Mail Extension (S-MIME)

Office 365 Message Encryption

Lab : Configure Office 365 Message Encryption

Configure Office 365 Message Encryption

Validate Information Rights Management

After completing this module, students will be able to:

Describe the various Microsoft 365 Encryption Options.

Describe the use of S/MIME.

Describe and enable Office 365 Message Encryption.

Module 11: Data Loss Prevention

This module focuses on data loss prevention in Microsoft 365. You will learn about how to create policies, edit rules, and customize user notifications to protect your data.


Data loss prevention fundamentals

Create a DLP policy

Customize a DLP policy

Create a DLP policy to protect documents

Policy tips

Lab : Implement Data Loss Prevention policies

Manage DLP Policies

Test MRM and DLP Policies

After completing this module, students will be able to:

Describe Data Loss Prevention (DLP).

Use policy templates to implement DLP policies for commonly used information.

Configure the correct rules for protecting content.

Describe how to modify existing rules of DLP policies.

Configure the user override option to a DLP rule.

Explain how SharePoint Online creates crawled properties from documents.

Module 12: Compliance Management

This module explains the Compliance center in Microsoft 365. It discusses the components of compliance score.


Compliance center

After completing this module, students will be able to:

Describe how to use compliance score to make organizational decisions.

Describe how assessments are used to determine compliance score.

Module 13: Insider Risk Management

This module focuses on insider risk related functionality within Microsoft 365. It covers not only Insider Risk Management in the compliance center but also information barriers and privileged access management as well.


Insider Risk

Privileged Access

Information barriers

Building ethical walls in Exchange Online

Lab : Privileged Access Management

Set up privileged access management and process a request

After completing this module, students will be able to:

Explain and configure Insider Risk Management in Microsoft 365.

Configure and approve privileged access requests for global administrators.

Configure and use information barriers to conform to organizational regulations.

Build ethical walls in Exchange Online

Configure Customer Lockbox

Module 14: Discover and Respond

This module focuses on content search and investigations. The module covers how to use eDiscovery to conduct advanced investigations of Microsoft 365 data. It also covers audit logs and discusses GDPR data subject requests.


Content Search

Audit Log Investigations

Advanced eDiscovery

Lab : Manage Search and Investigation

Investigate your Microsoft 365 Data

Conduct a Data Subject Request

After completing this module, students will be able to:

Conduct content searches in Microsoft 365

Perform and audit log investigation.

Configure Microsoft 365 for audit logging.

Use Advanced eDiscovery

Microsoft 365 Security Administration
Microsoft Administration resources
Killexams : Microsoft Administration resources - BingNews Search results Killexams : Microsoft Administration resources - BingNews Killexams : Microsoft Engineer Resource

Our Corporate client is actively sourcing for a a skilled Microsoft Engineer Resource to join their team. As a Microsoft Engineer Resource, you will play a crucial role in maintaining, optimizing, and enhancing the Microsoft technology stack to support the organization’s IT infrastructure and operations.

The ideal candidate for this position will have a strong background in Microsoft technologies, including Windows Server, Active Directory, Exchange, SharePoint, and Azure. You should have a deep understanding of system administration, configuration, and troubleshooting within the Microsoft ecosystem.

Desired Skills:

  • Microsoft Power Platform
  • Power Platforms Admin
  • Power App
  • Design
  • Develop
  • Power Automate Desktop flows
  • Power Automate Cloud Flows
  • Power BI report
  • Microsoft Prem Connectors
  • Microsoft Pre Databases
  • CICD
  • DevOps
  • Agile

Learn more/Apply for this position

Sun, 13 Aug 2023 11:59:00 -0500 en-US text/html
Killexams : Microsoft Cloud Security Woes Inspire DHS Security Review

The US Department of Homeland Security (DHS) late last week kicked off an investigation into the threat of cyberattacks against cloud computing environments as Microsoft faces intense scrutiny over its handling of a major attack on its Azure cloud infrastructure.

On Aug. 11, DHS announced the next project for its Cyber Safety Review Board (CSRB), a joint public-private subgroup which in the past year and a half has investigated the Log4j vulnerability, and the Lapsus$ group (the results of which were released on Aug. 10). This third endeavor will focus on "issues relating to cloud-based identity and authentication infrastructure affecting applicable CSPs and their customers," DHS said in an announcement.

Some experts consider the move a good start to mending what's broken in cloud security services today.

The CSRB review was spurred by the exact breach of Microsoft's Azure cloud service, prosecuted successfully by a Chinese APT which Microsoft tracks as Storm-0558. The campaign compromised dozens of public sector agencies, as well as many private companies, and the full scope of the damage is not yet clear. DHS "began considering whether this incident would be an appropriate subject of the Board's next review immediately upon learning of the incident in July," it noted.

"The exact Microsoft incident opened the door to this type of direct action, and DHS walked right in," explains Craig Burland, CISO at Inversion6. "While many will likely voice opposition to the government stepping, uninvited, into a new realm of regulation, organizations both large and small will benefit from a shift in shared responsibility to upgrade the default protections offered to all cloud clients."

Rebalancing Shared Responsibility in the Cloud

As Karen Walsh, CEO at Allegro Solutions, points out, the review is a step towards implementing the US National Cybersecurity Strategy's Objective 2.4, "Prevent Abuse of U.S.-Based Infrastructure," an initiative meant to disrupt and dismantle threat actors targeting American organizations.

Beyond this broader initiative, there's a deeper, more structural issue at hand.

Recent months have brought repeated instances of severe vulnerabilities in cloud infrastructure, even from the most sophisticated providers like Microsoft. AWS has leaked tokens, its new features have been compromised, and threat actors have regularly leveraged it to steal sensitive business data and perform follow-on attacks. Google Cloud has experienced its own issues with stolen tokens, as well as its database service and certain kinds of content, and has suffered its own breaches as of late.

Clearly the cloud is at risk, but end users often don't hear about it, because cloud providers manage their own systems. Without the need for customers to patch, the model for disclosure changes as well. For example, cloud vulnerabilities are not assigned traditional CVEs.

The lack of clarity in who bears what responsibilities in securing cloud environments, and how to communicate between vendor and customer, has begun to have serious ramifications in real world cyberattacks.

Microsoft in the Hot Seat

Some see Microsoft Azure as an example of where the shared responsibility model failed, because it wasn't merely that a hostile state-aligned APT breached Azure Active Directory (AD), affecting the government and up to millions of Microsoft 365 applications. The greater offense, they say, is the manner in which Microsoft has handled the disclosure and review process.

"For many customers and investors, it was disappointing to see Microsoft in the news yet again for security reasons," says Claude Mandy, chief evangelist for data security at Symmetry Systems. More than a month after the breach was initially disclosed, he emphasizes, "the details on how the breach occurred and its potential impact are still vague, with no certainty provided by Microsoft. Instead, concerns and assessments are only being raised by outside cybersecurity researchers. As an industry, we are demanding more transparency."

In particular, Mandy takes issue with how Microsoft, until recently, withheld security logging as an upcharge for 365 customers. Microsoft was "restricting companies from having essential security features unless they pay more," he says, putting a burden on its customers. Microsoft has since reversed this policy.

That sentiment was seconded by security researchers at Tenable, who on Aug. 3 published the details of an entirely separate Azure vulnerability enabling certain unauthorized access to cross-tenant applications and the sensitive data, including authentication secrets. "To provide you an idea of how bad this is, our team very quickly discovered authentication secrets to a bank," Tenable CEO Amit Yoran wrote in a LinkedIn post.

In a statement provided to Dark Reading, Microsoft claimed that the issue was mitigated for a majority of customers in June, and has since been fully resolved.

But Tenable researchers push back on that explanation, writing that "Microsoft has remediated this vulnerability for any new applications using the affected service, however, existing applications that were developed and deployed prior to that remediation are still affected and vulnerable."

A Microsoft spokesperson provided the following explanation:

"We appreciate the collaboration with the security community to responsibly disclose product issues. We follow an extensive process involving a thorough investigation, update development for all versions of affected products, and compatibility testing among other operating systems and applications. Ultimately, developing a security update is a delicate balance between timeliness and quality, while ensuring maximized customer protection with minimized customer disruption."

Can DHS Fix Shared Responsibility?

Walsh and others are hoping that the government action can help bridge the kinds of security and communications breakdowns at the heart of stories like these.

"As the CSRB engages more deeply in this review, cloud service providers will likely bear more burden under the Shared Responsibility Model. A major through line from the National Cybersecurity Strategy is shifting responsibility to organizations that have more resources. In this case, providers have more resources than their customers," she says.

Burland seconds the need to shift more security burden from customers to vendors. "Today, the CSPs hold much of the power in the shared responsibility model, essentially protecting their own assets while expecting less capable, less knowledgeable customers to do the same," he bemoans.

"If the findings of the CSRB spark immediate changes to the shared responsibility model, it will have been a success and further the administration's strategic goals. If the findings simply plant seeds that new regulations may be on the horizon, it will still be a success," he says. "In either case, the review will advance another chess piece forward on the board, positioning the government to demand and ensure a common defense against cybersecurity threats."

Tue, 15 Aug 2023 04:03:00 -0500 en text/html
Killexams : Microsoft Engineer Resource – Gauteng Johannesburg

Our Corporate client is actively sourcing for a a skilled Microsoft Engineer Resource to join their team. As a Microsoft Engineer Resource, you will play a crucial role in maintaining, optimizing, and enhancing the Microsoft technology stack to support the organization’s IT infrastructure and operations.

The ideal candidate for this position will have a strong background in Microsoft technologies, including Windows Server, Active Directory, Exchange, SharePoint, and Azure. You should have a deep understanding of system administration, configuration, and troubleshooting within the Microsoft ecosystem.

Desired Skills:

  • Microsoft Power Platform
  • Power Platforms Admin
  • Power App
  • Design
  • Develop
  • Power Automate Desktop flows
  • Power Automate Cloud Flows
  • Power BI report
  • Microsoft Prem Connectors
  • Microsoft Pre Databases
  • CICD
  • DevOps
  • Agile

Learn more/Apply for this position

Sun, 13 Aug 2023 11:59:00 -0500 en-US text/html
Killexams : Cybersecurity in the cloud coming into focus with CISA configurations, CSRB review

The Cybersecurity and Infrastructure Security Agency is about to provide cloud security across government a boost with the impending finalization of security “baselines” for widely used Microsoft applications.

Meanwhile, the hacking of a Biden administration cabinet member’s emails via Microsoft’s cloud environment has sparked a high-level government investigation into the incident, as well as broader review of cloud security best practices

CISA’s work under the “Secure Cloud Business Applications” or “SCuBA” project has been ongoing...


The Cybersecurity and Infrastructure Security Agency is about to provide cloud security across government a boost with the impending finalization of security “baselines” for widely used Microsoft applications.

Meanwhile, the hacking of a Biden administration cabinet member’s emails via Microsoft’s cloud environment has sparked a high-level government investigation into the incident, as well as broader review of cloud security best practices

CISA’s work under the “Secure Cloud Business Applications” or “SCuBA” project has been ongoing since 2021. The project aims to provide agencies and other organizations resources for securing their cloud environments. CISA released an initial set of security baselines for the Microsoft 365 suite of business applications last year for feedback from the technical community.

Grant Dasher, the architecture branch chief for the Office of the Technical Director for Cybersecurity at CISA, said the agency plans to release a finalized version of those SCuBA baselines in “the next short period of time.”

The baselines specify the implementation controls organizations can use to secure applications like Azure Active Directory. And CISA also developed an automated tool that organizations can use to evaluate their implementation of those controls.

“We’ve seen really across the cybersecurity industry, both inside the government and outside of the government, a use of that tool to start assessing the posture and configuration in these environments,” Dasher said at the FCW/NextGov Identity Summit yesterday. “And it’s been a helpful tool for us to work with the agencies to try and make sure that they’re implementing best practices in the cloud identity space.”

With the Microsoft 365 baselines set to be finalized in the near future, Dasher said CISA will also soon be releasing configurations for Google’s suite of cloud-based business applications. Earlier this summer, CISA also finalized the high-level architectural guidance for the SCuBA project, as well as a framework for ensuring agencies have visibility into threats in their cloud environments.

Dasher said the transition to cloud services gives organizations an opportunity to modernize and transform their identity infrastructure.

“Agencies are in a whole spectrum of different places,” he said. “Some have very robust, mature, existing identity infrastructure that they’re continuing to expand and leverage. Others are sort of redoing things in a more greenfield approach. Different agencies are taking different directions, but we’re trying to support and assist them in in that journey, and make significant progress towards these goals.”

For years now, federal officials have said the move to cloud computing will be a major boon for securing data and networks, while also cautioning the shift doesn’t eradicate the cybersecurity responsibilities of agencies.

Ken Bible, the chief information security officer at the Department of Homeland Security, commented that “identity in the cloud has become kind of the new attack surface,” pointing to a high-profile hack of Microsoft’s cloud-based email service.

“I don’t know whether it’s an offshoot directly of pandemic as much as it is the fact that when we started to make this move towards these cloud based services, it exposed that fact that there was a potential soft spot there that could be taken advantage of,” Bible said at yesterday’s Identity Summit.

The Cyber Safety Review Board announced last week that it would investigate the Microsoft incident, which occurred earlier this summer. It involved suspected Chinese hackers using a stolen Microsoft key to forge access to the cloud-based email accounts of Commerce Secretary Gina Raimondo and high-level State Department officials in what CISA called a “targeted” attack.

The board in a press release said its review will focus on the incident, as well as “the malicious targeting of cloud computing environments” and what government, industry and cloud service providers should “employ to strengthen identity management and authentication in the cloud.”

“The board will develop actionable recommendations that will advance cybersecurity practices for both cloud computing customers and CSPs themselves,” the press release states.

With agencies continuing to adopt cloud services, officials are keenly interested in further developing the “shared responsibility model” between cloud service providers and their customers.

“I think we’re in a point of irreversible momentum in terms of moving and continuing the migration towards cloud based capabilities,” Bible said.

Copyright © 2023 Federal News Network. All rights reserved. This website is not intended for users located within the European Economic Area.

Wed, 16 Aug 2023 04:07:00 -0500 en-US text/html
Killexams : Cyber experts say regulators aren't going far enough with their rules No result found, try new keyword!Around 49 percent of experts who responded to a Cybersecurity 202 survey said cyber regulators aren’t going far enough. Wed, 16 Aug 2023 23:34:09 -0500 en-us text/html Killexams : Commentary: Take no comfort in Big Tech’s commitment to responsible AI

In response to widespread concerns over artificial intelligence, representatives from Amazon, Google, Meta, Microsoft and OpenAI met last month with President Biden’s administration to help move toward safe and responsible AI technology.

As part of that meeting, the White House released a document that underscores the principles of safety, security and trust as fundamental to AI’s future. It is, however, quite surprising that the document available online does not mention the White House; it is void of any official signs such as standardized formatting, letterhead, authorship or source, signature, reference number or even a date.

These issues aside, when dealing with high-tech giants such as Amazon, Google and Microsoft, the notion of voluntary commitment is more like a joke than anything serious. Indeed, even in cases in which established laws exist and commitments are mandatory, these companies often have the financial and legal resources to navigate around them, sometimes pushing the boundaries of what’s permissible and bending the rules to their benefit.

Google and Amazon’s union-busting efforts, Facebook’s Cambridge Analytica scandal and Microsoft and OpenAI’s copyrights violations are only the tip of the iceberg, demonstrating that regulators already have a hard time enforcing existing mandatory laws. So how can voluntary commitments be expected to yield better results?

Regarding the challenges with implementation and effectiveness, the variability in interpretation stands out because companies could interpret and implement these commitments in dissimilar ways. Particularly in cases of potential competitive disadvantage – such as when abiding by these commitments could be against the financial bottom line – flouting or interpreting the guidelines in a lax manner could be a matter of life and death for these companies. This is likely given the international nature and implications of AI development.

The White House’s consultations with a broad spectrum of countries indicate an appetite for creating an international front to address these issues effectively. But history has shown that aligning on international agreements, especially on issues with deep economic implications, often yields more rhetoric than action. (Climate change and the Paris climate accord are a shining example.) Essentially, creating a cohesive and enforceable international framework clashes with the reality of geopolitical competition.

In the case of AI, America’s major technological competitor, China, is not listed among the countries the White House consulted with. Will the U.S. or its allies forgo a competitive edge by committing to guidelines and moral principles that other nations choose not adopt? Again, the example of climate change is illuminating. The U.S. and China are the world’s top two carbon emitters, and despite showing good intentions to curb their emissions, because they compete in developing solar energy equipment, their interests keep clashing, and consequently, global efforts to combat climate change are negatively affected.

Lastly, it is also important to note that voluntary commitments tend to offer false assurance, creating an illusion of safety and security, even when underlying issues persist and nothing changes in practice. What makes the notion of voluntary commitments in the case of AI more troublesome is that it puts users’ safety, security and trust at the mercy of companies that already have bad records and can use technological competition with China as a convenient excuse to disregard their voluntary commitments.

Thus, it’s vital to be critical toward soft measures such as voluntary commitments and advocate for devising more comprehensive and internationally inclusive solutions that include monitoring and evaluation regimes as well as sanctions for the companies and countries that don’t comply.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.

Sun, 20 Aug 2023 08:43:00 -0500 text/html
Killexams : The 30 young leaders who are forging a new future for the healthcare industry in 2023

Dr. Adrian Jacques Ambrose, 35, wants to make healthcare, especially mental-health care, more accessible.

Ambrose is a senior medical director in the Department of Psychiatry at Columbia University Irving Medical Center.
Columbia University Irving Medical Center

Ambrose, who goes professionally by Jacques, is driven by how confusing healthcare is. "You're expecting the consumer to diagnose themselves," he said. "It's so convoluted." 

As a senior medical director in the Department of Psychiatry at Columbia University Irving Medical Center, he oversees over 100 clinicians, including about 50 physicians across four clinical sites. He aims to ensure proper quality of care, proper access, and ways to better integrate a patient's clinical experience. 

One area of focus is mental health and encouraging employers to "begin that conversation, that difficult conversation, in an open and honest way," and that they "consider people as actual human beings who have challenges beyond what we see in the office." 

Ambrose emigrated from Vietnam to Hawaii when he was 9. "If you were to ask me, this refugee child, growing up in Hawaii, to a single mother who never graduated middle school, what was he going to do when he grew up, I would have said, 'Work at McDonald's like my mom.'"

He explained that he grew up in "a very impoverished neighborhood" and many of his friends are "still living in poverty." 

He remembers when he realized healthcare was his calling — during a fellowship at the Satcher Health Leadership Institute, working under David Satcher, the former surgeon general. 

Ambrose said he asked himself: "Where would you reconceptualize healthcare and where would you potentially think about potholes or deficits or gaps currently in the healthcare system for people that don't resemble the healthcare providers, which at the time was predominantly white and predominantly male."

He said his North Star is asking questions. "How do I continue to inculcate this dream of advocating for not only better healthcare, but better healthcare for vulnerable populations and minority populations?" he said.

Ambrose doesn't want patients to be left behind, especially those who may not have financial or social capital — or knowledge of the healthcare system. 

"I don't want to forget my roots, and I don't want to forget there are many, many families and people who still need a lot of help."

Josée Rose

Dr. Andrew Anzalone, 36, is pioneering a more precise approach to gene editing.

Anzalone is a cofounder of Prime Medicine.
Prime Medicine

By the time he finished his joint medical degree and Ph.D. program, Anzalone knew he wanted to focus on biomedical research.

Instead of continuing his medical training, Anzalone scored a postdoc position in the lab of David Liu at the Broad Institute. The lab has been at the forefront of discovering new ways to modify an individual's genetic information, and Liu has been spinning out those technologies into companies like Beam Therapeutics and Prime Medicine.

In Liu's lab, Anzalone helped develop a more precise way to modify DNA, called prime editing. Prime editing can alter, insert, or delete stretches of genetic material or individual letters.

After finishing his postdoc, Anzalone went to work with Liu as a cofounder at Prime Medicine, aiming to turn this technology into medical treatments. The company raised $315 million from top biotech VCs and went public late last year. It's now valued at $1.5 billion.

Theoretically, prime editing could help treat about 90% of genetic diseases, Prime Medicine said, and the company has named 18 it's going after first. Anzalone and his colleagues said the technique has worked in petri dishes and in animal experiments.

But while gene editing holds the promise of providing cures, or at least highly effective treatments, for many diseases that are now untreatable, there's lots of scientific work still to be done, and it could be years before we find out whether the technology can live up to its promise.

Anzalone and his colleagues want to start testing the technology in people, and Prime Medicine is asking US regulators for permission to do that next year. The company wants to examine whether prime editing can help treat chronic granulomatous disease, a blood-cell disorder that weakens the immune system.

"What fuels the excitement is that we could potentially address many of these things that haven't really had a therapeutic approach," Anzalone said. "And we can get at the root cause."

—Zachary Tracer

Virgílio Bento, 39, offers virtual physical therapy to millions of patients worldwide.

Bento is the founder and CEO of Sword Health.
Sword Health

Bento was 8 years old when his brother fell into a coma after a car accident. When his brother woke up a year later, he needed intensive physical therapy, but that care wasn't available where the family lived in Portugal — forcing Bento's brother to seek care at a high-intensity rehabilitation center in Cuba for three months.

The experience stuck with Bento, he told Insider, as a prime example of the inaccessibility of traditional physical therapy.

In 2009, Virgilio Bento began his Ph.D. in electrical engineering at the University of Aveiro in Portugal. He dedicated his thesis to building the technology behind Sword Health. He wanted to create an affordable virtual-physical-therapy platform to help people suffering from pain associated with musculoskeletal conditions with personalized treatment plans and remote monitoring devices.

Bento made Sword Health available to US patients in 2020. Since then, the company has seen explosive growth, raising $316 million in venture capital and hitting a $2 billion valuation with its November 2021 Series D round.

Sword now works with more than 2,500 employers around the world, Bento said. The company surpassed $100 million in recurring revenue from annual contracts with employers earlier this year and hopes to end 2023 with $200 million.

Bento said Sword has continued to grow despite the economic downturn because the technology saves money for employers. Musculoskeletal conditions like back pain affect about 1.7 billion people globally, and cost hundreds of billions of dollars every year in healthcare bills and lost wages.

"Instead of having low-back-pain surgery, you can do Sword, which will get you better clinical outcomes and save your company money," Bento said.

The company is expecting to become profitable as soon as 2024, Bento said. And once Sword becomes profitable, he said, an IPO could be just around the corner.

—Rebecca Torrence

Joel Bervell, 28, is teaching doctors, patients, and politicians at the White House to challenge what they know about race in medicine.

Joel Bervell.
Joel Bervell

Bervell said he mapped out his entire career in medicine on a posterboard when he was 12. 

"I was going to go to Yale or Harvard, I was going to go to medical school, and I was going to become a surgeon," he said.

So far, so good. A Yale graduate, Bervell is a fourth-year medical student at Washington State University. He's planning to go into orthopedics — the "whitest" medical specialty, with nearly 84% of surgeons identifying as white, 2022 data from the Association of American Medical Colleges found.

But Bervell never predicted that along the way, he'd become a leading medical voice on social media. It all started during the COVID-19 pandemic when Bervell began questioning some things he was being taught on Zoom. 

"Things like, 'Black patients are more likely to have asthma,' yet we don't talk about redlining," he said. "'Black patients are more likely to die of COVID,' but yet we didn't dive into the social determinants of health."

He started noticing all the subtle — and not-so-subtle — ways racial bias affects care, starting when doctors are trained. 

Bervell began using TikTok and Instagram to tell stories about disparities, such as showing how pulse oximeters perform worse on darker skin, revealing how conditions like eczema and psoriasis actually look on different skin tones, and exploring why an outdated, racist measure of kidney function disqualified more African American patients from transplants. 

The Ghanaian American "Z-illennial" bridges different cultures and generations with savvy storytelling and science communication. He's been tapped by the American Medical Association, the World Health Organization, the US Surgeon General, and the White House for his social-media skills. 

Back home in Portland, Oregon, he also gets recognized: "Hey, I follow you on Instagram!" someone shouted out their car window recently. Another follower said she had a precancerous mole removed after she watched his video on acral lentiginous melanoma.

"Things like that really inspire me," he said.

Hilary Brueck

Kyunghyun Cho, 38, is pushing the boundaries of drug discovery at a major biotech firm.

Cho cofounded Prescient Design.
Kyunghyun Cho

As a machine-learning pioneer, Cho's research was a precursor to today's most advanced artificial-intelligence systems, like that underpinning the breakthrough app ChatGPT.

It propelled him into academia, and eventually, medicine. 

At New York University, where Cho, age 38, is a prolific associate professor, he helped build a data-science hub for healthcare and studied how algorithms can make a difference for patients. One of his ongoing efforts is using them to Strengthen screening for breast cancer.

Eventually, Cho landed on an idea that needed more resources. 

Together with Richard Bonneau and Vladimir Gligorijevic, standouts in molecular design and bioinformatics, Cho cofounded a startup called Prescient Design with the goal of using advances in machine learning to discover medicines more efficiently. 

Other companies have pursued that, but Prescient envisioned a unique approach of using algorithms to design proteins, the basis of many medicines, with more input from lab workers, allowing science and math teams to work together more easily.

Since getting acquired by the biotech company Genentech in 2021, the Prescient program has grown more adept at designing proteins, Cho said, but it also works across the different "modalities" or classes of medicine, giving researchers an incredibly powerful tool kit.

While the Prescient team hasn't yet discovered a breakthrough treatment per se, their technology has been deployed across Genentech to aid a number of active projects, Cho said.

Similar to his work at NYU, Cho tries to foster a collaborative environment at Genentech, hiring computer scientists and biologists in equal numbers.

— Blake Dodge

Kavelle Christie, 39, is fighting for Black maternal health and to safeguard reproductive rights.

Christie is the director of the Gender Equity and Health Justice Program at Community Catalyst.
Community Catalyst

When Christie was pushing for legislation in 2018 to cement abortion rights under Rhode Island state law, she heard repeatedly that the bill wasn't urgent. With Roe v. Wade in effect, abortions were legal across the US.

But Christie, who was working at Planned Parenthood of Southern New England at the time, saw reproductive rights were in danger. 

The Rhode Island law passed in 2019, three years before Roe v. Wade was overturned. In 2020, Christie joined the healthcare advocacy organization Community Catalyst as its director of gender equity and health justice to fight for reproductive rights and health equity on a national level.

At Community Catalyst, Christie helps create policies such as the Black Maternal Health Act of 2021 and an upcoming bill focused on the impact of long COVID on maternal health.

Christie also advises state and private organizations on increasing access to midwifery services and helped push for a Rhode Island bill, passed in 2021, that made doula services eligible for reimbursement by private insurance and Medicaid.

She's spent years on voter-organization efforts, too, including managing a voter-engagement campaign in 2020 focused on Latino voters in Colorado, which helped protect access to abortion in the state.

Those rights, and reproductive privacy as a whole, remain under fire across the US. Christie pointed to "personhood" laws proposed in various states that would categorize a fetus as a person and grant them a constitutional right to life.

Christie said she worries that the personhood laws could impact fertility care for some, such as barring the creation of frozen embryos in assisted reproduction, and hopes to do more work in the future to protect access to those services.

—Rebecca Torrence

Rivka Friedman, 40, is using the vast resources of JPMorgan to make healthcare better and cheaper.

Friedman is in charge of innovation at Morgan Health.
Morgan Health

After helping hospitals respond to the Affordable Care Act, Friedman, a consultant at the time, wanted to be in the room where policy was made.

In 2016, she joined a venture with the US Centers for Medicare and Medicaid Services to find ways to improve patient care while lowering the government's costs.

Like a startup, the CMS innovation center saw industry-shaping wins sprinkled with many failures, Friedman said.

An effort led in part by Friedman showed that you could lower individuals' healthcare costs by supporting their social needs, which helped spawn several digital-health startups.

Another program attempted to address maternal-health-provider shortages by giving Medicaid beneficiaries access to midwives, but the savings were too small, she said.

In 2021, when JPMorgan launched a venture meant to shake up the healthcare industry, Friedman saw an opportunity to apply what she'd learned to employer-sponsored insurance, which is how the majority of Americans pay for care.

She's now in charge of innovation at the bank's Morgan Health unit, which is tasked with lowering costs and improving care quality for the bank's 385,000 employees and dependents and for commercial healthcare more broadly.

One element of Morgan Health's strategy is working closely with startups to run pilots for JPMorgan's workers and their families to find ideas worth building on.

Thus far, a Columbus-based pilot in primary care is going well. Friedman's team has many more experiments planned, she said.

One will have the former CMS leader once again tackling maternal health, where people of color see worse outcomes regardless of income, she said.

Though it's still early, Friedman's team aims to support pregnant people more holistically, outside of their "capital-M medical needs," she said.

Friedman said she hopes to publish details about Morgan Health's work with providers, so other employers can replicate them. She said the right interventions exist — they're just not being implemented enough.

"If we can change that even modestly, I will feel really proud," she said.

— Blake Dodge

After losing a loved one to an overdose, Zack Gray, 34, is expanding access to addiction treatment for others.

Gray is Ophelia Health's CEO and founder.
Ophelia Health

In 2019, as Gray was Getting ready to graduate from Wharton Business School, a woman he loved died.

Unable to get a prescription for Suboxone, a medication that eases opioid cravings, she bought some illegally before dying from what Gray suspects was an overdose.

After reading books about addiction and talking to doctors, Gray was bewildered to learn how common her experience was.

"The fact that I didn't have a healthcare background wasn't all that relevant," he said. "It was about redesigning the evidence-based treatment to be more accessible to people who wanted it."

Later in 2019, Gray founded Ophelia Health, which helps treat opioid-use disorders by making Suboxone available online. Since the market downturn, the Wharton grad has been focused on building Ophelia into a sustainable business, which is no easy feat in addiction care. 

Many of Ophelia's contracts with health plans are "fee-for-service" arrangements, which means the company is paid per visit. That leaves out a lot of other services Ophelia provides for patients, such as helping them find pharmacies and get their care covered by insurance.

About 75% of Ophelia's patients have insurance via the state-federal health plan Medicaid, and Medicaid's reimbursement rates are low.

To boost revenue over the past quarter, Gray has doubled the percentage of patients covered by more lucrative contracts with insurers, in which they pay Ophelia flat monthly fees.

Among Ophelia's insured patients, 70% are still in care a year after starting treatment, Gray said. So for insurers, the upfront investment in Ophelia is worth it. 

But Gray is proudest that Ophelia provides care to people with no other options, and the startup will continue taking patients regardless of how they or their health plans pay for it.

Internal surveys at the company found many patients don't have primary-care doctors or any other touchpoint to the rest of the healthcare system.

— Blake Dodge

Hakan Kardes, 36, is using data and AI to help clinicians provide proactive care to seniors.

Kardes is the chief technology and experience officer at Alignment Health.
Alignment Health

A common gripe about the US healthcare system is that a patient's data is often scattered in different places that don't communicate with each other.

That can make it tough for a single healthcare provider to get a complete picture of a patient's health, leading to redundant tests and a frustrating experience.

"There are so many different silos of data. All these different entities are disconnected, and it puts seniors in a very tough situation to navigate all this," said Kardes, the chief technology and experience officer at Alignment Health, an insurer that serves seniors enrolled in the privatized version of Medicare.

Kardes is the lead architect behind AVA, the proprietary technology that powers the insurance company. His goal in building it was to break down those data silos, allowing Alignment to take better care of its members.

AVA — short for Alignment's Virtual Application — gathers data from hundreds of different sources, such as hospital visits, medical claims, and lab results, to provide an accurate account of a patient. 

It then applies more than 200 different AI models to make predictions. It can tell Alignment which members are likely to become hospitalized or develop a chronic disease, for example, and helps clinicians respond. 

The company's in-house team of healthcare providers use information from AVA to focus on those high-risk, costly patients and try to keep them healthier and out of the hospital.

Next up, Kardes is exploring ways that new generative-AI technology could save healthcare providers time. A doctor could ask a generative-AI tool for a member's most exact A1C test results and get the answer instantly, rather than having to comb through lab reports, he said.

— Shelby Livingston

Sasha Kelemen, 35, is securing the financial future of women's health.

Kelemen runs the only women- and family-focused healthcare investment-banking practice.
Sasha Kelemen

While at Goldman Sachs, Kelemen held her own at tables full of primarily white men and got promoted to vice president.

She planned to stay, but things changed after the investment banker had her first daughter. 

While on maternity leave in November 2020, she read everything possible about women's health and felt there was untapped potential. 

"There's something here," Kelemen said of her thinking at the time. "Why is nobody on Wall Street paying attention?"

In summer 2021, the bank SVB Leerink recruited Kelemen. In a 90-minute meeting, she pitched Barry Blake, a top banker there, on creating a team to land deals in women's health.

But as a working mom at Goldman — short on time while weaning the baby off breast milk and caring for her when she got sick — she also told Blake about her family and intentions to grow it.

Blake endorsed both of Kelemen's plans.

Now, at Leerink Partners, Kelemen runs the only women- and family-focused healthcare investment banking practice, staffed by a small team of female bankers, on Wall Street. And every day, her calendar is blocked from 6 p.m. to 8 p.m. so she can spend time with her kids.

Part of Kelemen's challenge is convincing largely male investors of the value of companies that treat menopause, pelvic-floor dysfunction, pain during sex, and other elements of a woman's healthcare journey.

Last year, Kelemen sold a menopause-treatment startup to a national OB-GYN services company. It was the first deal Kelemen put together from start to finish, and the first time her client, the startup's CEO Jill Angelo, wasn't a man. 

Right after the deal was announced, Kelemen hung up the phone and kissed her second daughter, who was then about 5 days old, on the head, thinking she might have better access to care one day. Then she started to tear up.

Kelemen added that other than that, she didn't work during her maternity leave.

— Blake Dodge

Robert Krayn, 35, is building a better workplace for mental-health professionals.

Krayn is the CEO and cofounder of Talkiatry.

Living in New York, Krayn didn't think he'd have difficulty finding a mental-health professional after experiencing a traumatic event.

He couldn't have been more wrong.

"I had great health insurance and was living in a populated city in terms of finding available psychiatrists," Krayn told Insider in an interview. "But it took several years of trying to understand why I was having a problem with access and not finding the solution I was looking for."

A finance professional and alum of Rutgers University, Krayn became obsessed with the pain points in the mental-health care system. He came to realize that many clinics and startups were not meeting the needs of providers and insurers, which in turn meant that patients were also suffering.

"There's a shortage for mental-health care, but lots of people aren't solving the problem in the right way and aren't meeting the needs of all stakeholders," he said. 

In 2019, this realization led Krayn to leave finance to launch Talkiatry, a national mental-health-care practice that provides in-network psychiatry and therapy. The startup has raised $115 million in VC funding.

Unlike some other mental-health startups, Talkiatry employs psychiatrists as full-time, salaried workers. Krayn said that while this approach is more expensive, it sets Talkiatry apart as a better place for mental-health professionals to work, which in turn translates to more and better care for patients.

"Talkiatry believes you can't just increase access, but you have to increase access to quality care," he said. "We hire the best-quality providers and have a clinical-leadership structure where we can manage a large patient population and produce better outcomes."

—Samantha Stokes

Noah Lang, 39, wants to make it easier for gig workers to get health insurance.

Lang is the cofounder and CEO of Stride Health.
Stride Health

Americans are changing their relationship with work. Many are less loyal to their jobs, and a growing number of people are ditching a traditional nine-to-five entirely in favor of freelance work.

But with health insurance in this country largely tied to employment, it can be difficult for people to access quality healthcare while pursuing their career goals.

That's where Noah Lang comes in. A longtime leader in the tech and healthcare space, he's passionate about overhauling the relationship between jobs and health insurance. 

"The average American works more than 12 jobs in their lifetime," he told Insider. "We need a benefits system built around people, not around one company."

In 2013, Lang launched Stride Health, which helps independent workers find affordable health insurance. The startup has raised $96 million in funding and counts Venrock, F-Prime Capital, and Kleiner Perkins as investors. 

Stride was founded soon after the passage of the Affordable Care Act, which allowed people to get access to health coverage regardless of gender or health condition or where they lived, even if they didn't get insurance through work.

"The whole sector was being disrupted," he said.

Ten years into Stride Health's existence, Lang said the company has worked with three presidential administrations to increase access to different forms of healthcare, and it continues to reimagine what the industry should look like. About 3.5 million people get health insurance or other benefits via Stride, the company said.

"The thing that motivates me is building a new benefits system," he said. "We worked with the Obama administration and convinced them to build a private-sector integration with, and that work was finished with the Trump administration. Now we're scaling with the Biden administration."

—Samantha Stokes

Julia Leach, 36, is designing glasses and headphones that could help protect Alzheimer's patients' brains

Leach is the head of translational research at Cognito Therapeutics.
Julia Leach

Leach spends a lot of time trying to look at the world through the eyes of an Alzheimer's patient. Sometimes, quite literally — as she dons big, dark glasses and headphones she's designing for people with mild cognitive impairment, Alzheimer's, and Parkinson's.

The headsets she designs as the head of translational research at Cognito Therapeutics emit bright flashing lights and sounds tuned to particular frequencies. This combination is meant to serve as a kind of disruptive exercise session for the brain, slowing cognitive decline and brain decay.

Early evidence suggests the therapy may work, at least among patients with mild to moderate Alzheimer's disease. Some patients also report better sleep, a nice bonus.

"What I personally hope to provide back to these individuals is that feeling of themselves — whether that's a memory, whether that's a smell that links to a memory, whether that's just being able to get up and go for a walk outside," Leach said.

Leach lost her grandmother to Alzheimer's 5½ years ago, so the work is deeply personal.

"She was the one who sparked my love for science," Leach said. "She always encouraged me to push and to grow and to learn."

Imagining her declining grandmother using Cognito's device grounds and motivates Leach's research, as she considers how to Strengthen device comfort and usability.

Cognito's therapy is now being tested in a large, yearlong trial of more than 400 Alzheimer's patients across the US to determine how well it works. If successful, it could be on the market as early as 2026.

— Hilary Brueck

Christopher McGhee, 33, is working with hospitals to bring care into the home.

McGhee is a cofounder of Current Health.
Current Health

As a medical-school student in Scotland, McGhee cofounded Current Health in 2015 to help expand access to acute at-home care. But it wasn't until the coronavirus pandemic hit in 2020 that business exploded.

McGhee built Current Health's remote-monitoring platform, with tools like video visits and wearables, to provide home care to patients who would otherwise be in the hospital for conditions ranging from cancer to broken bones. During the pandemic, patients were desperate to get care virtually or in their homes, rather than going to the hospital and risking infection.

Revenue surged "basically overnight," said McGhee, and the UK-based company landed multiple partnerships with health systems in the US.

On the back of that growth, Best Buy bought Current Health in October 2021 for $400 million. The electronics-retail giant helps customers set up the remote-monitoring technology at home.

Following the acquisition, Current Health had its best year so far in 2022, which McGhee attributed to growing consumer preference for care at home and to increasing financial incentives for at-home care, including in Medicare and Medicaid coverage. The company has notched partnerships with more than 50 healthcare organizations globally, including five of the US's 20 biggest health systems, per Best Buy.

McGhee, who still serves as Current Health's CEO, also advises Best Buy Health on its virtual-care strategy. Best Buy's sales have been slipping for over a year, but the retailer has continued to invest in its healthcare business.

McGhee said Current Health plans to announce more health-system partnerships in the coming months and wants to add more automation into its platform to ease the burden of certain administrative tasks for clinicians.

— Rebecca Torrence

Dan Miller, 38, is tackling health disparities by providing better care to people of color.

Miller is the founder and CEO of Spora Health.
Spora Health

Miller was at a Black Buddhist retreat in the San Francisco Bay Area when he came up with the idea for Spora Health, a startup that provides virtual healthcare for people of color.

The retreat was the first time he'd experienced mindfulness and meditation in a space designed for a specific culture. Folks were elated to "learn from one another, have conversations with one another" and talk about their experiences as Black Americans, Miller said.

He knew immediately that the same sort of space should exist in medical care, where people of color experience discrimination and worse outcomes than white people. He founded Spora in 2019 to address these problems by providing care informed by the culture of the populations it serves.

"This culture-centered approach was a hypothesis that if we do this well, at a minimum we can create more access to care," Miller said. "At most, we will save lives," he continued. "And, thankfully, I can say that we've done both."

The San Francisco-based company, which has raised $4.1 million, cares for thousands of patients in more than 22 states and will expand to the rest of the US later this year, Miller said. About three-quarters of Spora's providers are people of color, and the startup also trains clinicians to provide culturally competent care.

Miller's proudest accomplishment is building Spora Mommas, a program that aims to Strengthen maternal health outcomes for Black mothers, who are more likely to die during pregnancy than white women. Spora has helped facilitate more than 100 births in the year since it launched, Miller said.

"We're getting baby photos in, and our babies are like eight months after being born. They're still healthy and our mommas are doing well. That's the thing that I'm most proud about. It's incredible." 

— Shelby Livingston

Manav Sevak, 26, and Kunaal Naik, 27, are creating a more robust system for managing care plans.

CEO Sevak, left, and Naik, the chief technology officer, cofounded Memora Health.
Memora Health

While in college at Georgia Tech, Sevak and Naik had a friend who was diagnosed with a chronic condition. Although this person was young, tech-savvy, health literate, and had great access to healthcare, they still struggled to communicate with their care team and follow a care plan.

Sevak and Naik realized that their friend's experience was just the tip of the iceberg when it came to care-management problems. 

"We came to the ultimate realization of just how broken the healthcare experience looks and feels for lots of different people, which inspired us to dig a little deeper into the problem space," said Sevak.

The pair were initially on different paths in college — Sevak wanted to become a doctor, while Naik was studying computer science — but their quest for a solution led them to found Memora Health, a company that digitizes and automates care plans with the help of AI. Since launching in 2017, the startup has raised $80.5 million from VCs including General Catalyst, Andreessen Horowitz, and AlleyCorp.

Memora started as a medication-management platform that would send automated reminders to patients when it was time for their next dose. The startup has expanded to become a holistic program managing patients' entire care regimens, from doctor visits to medical history to insurance reimbursements.

Naik, the startup's chief technology officer, said that AI has been integral in growing Memora Health into a care-management program, and that machine learning is being used to figure out the best time of day to message patients and anticipate when they may have questions.

"This is a conversational way to ultimately interact with clinicians," he told Insider in an interview. "The AI can answer routine questions about medications, surgeries, and appointment visits, but if AI can't confidently answer the question, it will redirect to a care team member."

—Samantha Stokes

Colleen Nicewicz, 38, is expanding much-needed addiction care at a measured pace.

Nicewicz is the CEO of Groups Recover Together.
Groups Recover Together

After helping lead Athenahealth, the medical software giant, through a major crisis, Nicewicz wanted to use her business chops to help patients more directly.

In 2019, having seen the toll of addiction in her own family, she took a role as COO at Groups Recover Together, a startup that treats opioid-use disorder, before becoming its CEO in 2020.

Groups had a unique approach to addiction medicine. Besides prescribing medication like Suboxone, which reduces cravings for drugs, Groups also required group therapy, allowing patients to form lasting connections, and outfitted clinics with bright colors and snacks.

Clinically, it was working. But financially, Groups needed to grow the business and get paid more. For the past four years, that's been Nicewicz's focus.

When she joined, most of Groups' revenue came from patients paying with cash and health plans reimbursing it for service. In addiction care, that often isn't enough to sustain a business.

Groups was eventually able to show insurers that it saved them money, Nicewicz said. As patients stopped using drugs, they needed less medical care, Groups data showed.

Now, health plans pay Groups a premium. The vast majority of its revenue comes from insurers paying set monthly fees for patients. Those fees are typically more than threefold what Groups would otherwise be able to charge for their care, Nicewicz said.

The model has allowed Groups to expand to more than 15 states while focusing on patients that need it most. Seventy percent of the 16,000 patients it sees each week have Medicaid, the government-sponsored insurance program for people with lower incomes, she said.

While Nicewicz has ideas to expand to provide mental-health services, the CEO is in no rush. 

Remembering lessons from Athena, where Nicewicz ran cost-saving programs and eventually the company's sale, she shies away from the "growth at all costs" mindset, she said.

— Blake Dodge

Alfredo Quijano Rubio, 30, is developing a better way to make medical diagnostics.

Quijano Rubio is the chief scientific officer and a cofounder at Monod Bio.
Monod Bio

Quijano Rubio has long had a passion for pushing the boundaries of science then turning his discoveries into business ideas.

"My passion was entrepreneurship," he said. "I've always been the kind of person that is, 'Oh, you're working on that project, why? Why is that useful?'"

Quijano Rubio grew up in Valencia, Spain, and studied biotechnology at the Universitat Politècnica de València. He won a prestigious scholarship to continue his education and earned his Ph.D. under David Baker at the Institute for Protein Design at the University of Washington. 

He's already cofounded two companies based on his work on custom-designing proteins. The first, Neoleukin, focused on creating better cancer treatments. The second company is Monod Bio, a spinout from Baker's lab that's aiming to create better medical-diagnostic tools. Monod started in late 2021 and raised a $25 million seed round in 2022. 

Monod relies on proteins that are designed to bind to a particular substance and emit light based on the amount of that substance that's present. Quijano Rubio has published research showing this method can detect things like the novel coronavirus and troponin, a protein that can signal a heart attack. 

The company envisions creating a device that can be used in a hospital or clinic in place of some lab draws. In theory, this could make some labs faster, easier, and less expensive, Quijano Rubio says. 

Quijano Rubio said the company is working to develop tests in areas such as cardiovascular disease and hormonal diseases, but declined to name particular ones. The company isn't pursuing tests for infectious diseases like COVID-19 right now.

—Zachary Tracer

Kuldeep Singh Rajput, 31, is combining wearable technology and AI to track patients at home and Strengthen their health.

Rajput is the founder and CEO of Biofourmis.

Rajput dropped out of a Ph.D. program in neuroscience in 2015 and started Biofourmis, a company that uses wearable sensors, artificial intelligence, and data analytics to help hospitals track and care for patients in their homes.

This was the year the Apple Watch became available, and fitness trackers were catching on. At the same time, the US Food and Drug Administration was starting to clear wearable medical devices for certain uses, Rajput said. 

But he was more interested in what could be done with all the data this new technology produced.

The idea behind Biofourmis was, "can we leverage all these passively captured data from patients to really be able to predict complications and deterioration?" he said. 

Biofourmis, which has raised $465 million in venture funding, works with hospitals to monitor and manage patients at home. It also works with pharmaceutical companies to manage clinical trials. It aims to detect problems and predict when patients' conditions might worsen, so doctors can step in early. Its software also provides recommendations on next steps, such as adjusting medication, Rajput said.

"Where typical remote monitoring has failed is: How do you act on that data to drive outcomes?" he said. "We wanted to focus on how do we use that data to influence outcomes, drive better patient outcomes, and save costs for our partners?"

The company initially worked with hospitals to take better care of their patients. About a year and a half ago, it branched out into providing care itself, which helps hospitals dealing with staffing shortages and frees up their beds for more patients, Rajput said.

While the company is growing rapidly — it managed more than 100,000 patients in 2022 and hopes to double that figure this year, Rajput said — its mission has always been to tailor care to the individual, he said.

"There's been a lot of talk about personalized medicine, precision medicine," Rajput said. "We have been actually doing it for many years now."

— Shelby Livingston

Holly Rees, 30, is innovating at the cutting edge of gene editing.

Rees is associate director and head of lead discovery at Beam Therapeutics.
Holly Rees

Rees is at the forefront of perfecting a type of gene-editing technology called base editing. Base editing lets scientists change the individual letters that make up an individual's genetic code, or DNA. The hope is that these tiny edits can help treat or even cure diseases.

Rees is the associate director and head of lead discovery at the biotech company Beam Therapeutics. Her work is focused on finding new base-editing tools to target different diseases and making these tools more effective and less prone to errors.

Beam's most advanced projects focus on the blood disorders sickle-cell disease and beta thalassemia, and on treating certain kinds of severe cancer. Meanwhile, Rees is focused on the other end of the spectrum — scientific advances that are still in their infancy but that could one day help treat diseases in people.

Rees told Insider that she can't publicly discuss most of the diseases she's working on, though she's involved in the company's efforts to treat hepatitis B. It's difficult to say when her work will make its way to treatments used in people.

"My hope is that a lot more patients who are currently suffering from rare or common serious diseases will have options provided to them for curing those diseases in a onetime therapy or single-administration therapy that has been enabled by base editing," Rees said. 

Rees earned her undergraduate degree in natural sciences at the University of Cambridge in the UK, before pursuing a Ph.D. at Harvard in the lab of David Liu. Liu is a cofounder of Beam, and two of his students — Nicole Gaudelli and Alexis Komor — helped invent key parts of base editing. Rees worked closely with them to build on their discoveries, an effort that continues at Beam. 

—Zachary Tracer

Jayodita Sanghvi, 38, is designing tech to help people get better healthcare faster.

Sanghvi is the senior director of data science at Included Health.
Included Health

Grand Rounds, now called Included Health, was started in 2011 to help people with complex medical conditions connect with experts to get second opinions.

Sanghvi joined the company three years later, after getting her Ph.D. in bioengineering from Stanford University. She wanted to use her skills in computational biology and statistics to make a difference in patient care.

So she helped build Grand Rounds' provider-matching service, which uses machine learning to determine which provider is most likely to provide the best outcomes for a given patient. The service separates out decisions as granular as which provider is the best at getting patients to stay on medication, or which has received Good Score in communicating with patients.

The tech brings big savings for the more than 300 employers and health plans that Included Health works with, too — last year, Provider Match helped drive a few hundred million in cost savings for those companies, thanks to decreased medical events like hospitalizations and better outcomes for patients, according to Included Health.

Grand Rounds merged with Doctor on Demand to become Included Health in 2021. Sanghvi now leads Included Health's data-science team as its senior director.

Sanghvi and her team also built automation tech that predicts which patients are likely to have a "care episode," such as a cardiovascular event, so they can get to the care they need faster.

Sanghvi said she wants to build patient trust in healthcare by using technology. At the moment, that trust is sorely lacking, she said. 

"We're not there in health, but we're there in so many other industries," she said. "There's a huge opportunity to bring that to healthcare, instead of patients trying to avoid it or hating it every time they need care."

—Rebecca Torrence

Neil Sanghavi, 34, is helping doctors provide better care by equipping them with on-demand evidence from millions of patient records.

Sanghavi is the president of Atropos Health.
Neil Sanghavi

New ideas and pilot programs at hospital systems often peter out before they get the chance to reach the masses. Atropos Health, a clinical-consultation startup born from a pilot at Stanford Healthcare, is a rare success story.

It's on the way to being one, at least. It's Sanghavi's job to make that happen.

Sanghavi is the president of Atropos, where he's helping to develop its product and bring it to health systems around the country. He joined the company as part of the founding team in 2021. He previously held strategy and leadership roles at Haven, Centivo, and the Cleveland Clinic.

At its core, Atropos aims to help doctors provide better care based on evidence from past patients' cases. "What we're talking about is changing the way that every physician and physician-patient combination make decisions about the care that's being delivered," Sanghavi said.

Spun out of a Stanford research project begun in 2011, the company answers doctors' questions by aggregating and analyzing data from millions of anonymous patient records. Atropos physicians review the analyses and write short summaries doctors can use to help them make treatment decisions.

And Atropos can do this in two business days, whereas a similar-caliber study could take 10 months in a research setting, Sanghavi said.

A big part of Sanghavi's job is getting health systems to adopt Atropos' service. That means making sure clinicians trust its analyses. While it's early, the company's already being used by thousands of doctors at a handful of institutions, he said.

In late 2022, Atropos clinched a partnership with Mayo Clinic — a deal orchestrated by Sanghavi over 18 months. "That was kind of our first big stamp of approval after Stanford," Sanghavi said.

— Shelby Livingston

Robin Shah, 36, is guiding patients with cancer through treatment and improving their health outcomes.

Shah is the founder and CEO of Thyme Care.
Thyme Care

Robin Shah has been around cancer care for just about his entire life.

The son of an oncologist, Shah got a crash course in operating a cancer center when he began working at his father's practice while in college. Next up was Flatiron Health, where he built tools to help doctors shift their cancer practices to new ways of getting paid that reward better care. In 2018, he helped launch OneOncology, a network of independent cancer practices.

Between these day jobs, Shah helped friends who needed assistance navigating a cancer diagnosis, he said.

In one case in 2019, the mother of Shah's high-school friend was told by her primary-care doctor she may have cancer but would have to wait at least a month to see an oncologist. Shah connected her with his father, who ordered tests within a day to confirm her diagnosis of stage 4 pancreatic cancer and started her treatment 36 hours later.

"Who knows what a four- to five-week wait just to get a consult, to get the test ordered, to then come back to get a treatment plan would've done?" he said.

The experience prompted him to build Thyme Care to help guide people through cancer treatment. The company, which has raised $22 million, helps patients understand their diagnosis, manage symptoms, and schedule appointments. It also connects patients to resources such as meals and transportation, Shah said.

Thyme Care is working with about 1,600 patients and expects to double that number by the end of the year, Shah said. Beyond improving care for these patients, Shah said he's excited about the talented workers that companies like Flatiron, OneOncology, and Thyme have recruited to help Strengthen cancer care.

"We've attracted amazing talent and I think it has permeated to additional companies being built in the healthcare space," Shah said. "I am so excited about the impact, not just me, but everybody that's working in this space is going to have on healthcare for the next 20 years."

— Shelby Livingston

Stephen Smith, 29, is building an app to provide patients access to better care for OCD.

Stephen Smith is the founder and CEO of NOCD.

When he was 20 years old, Smith left college and became housebound because of his obsessive-compulsive disorder. After experiencing misdiagnoses and ineffective treatment, he ended up waiting seven months to see a clinician trained in specialized OCD care. The cost was $400 a session.

The treatment he received, called exposure and response prevention therapy, helped Smith recover so he could return to college. 

But the lack of specialists trained to provide ERP therapy means that of the 2.5 million US adults with OCD, few can access the care that worked for Smith.

Smith started NOCD in 2014 to bridge that gap. The Chicago-based startup connects patients with licensed therapists who provide virtual ERP therapy for OCD. Patients can also access peer communities and self-help tools through NOCD's app.

"Our goal is to ensure that everyone in the US, no matter where you live or how much money you make, can access this treatment," Smith said.

NOCD provides its clinicians with ERP therapy training, and the company built its own electronic-medical-records system to better monitor its patients' progress.

Today, NOCD is available in all 50 US states and internationally, and tens of thousands of people get therapy through NOCD, Smith said. About 130 million people in the US can use insurance to pay for NOCD's services, he added. Without insurance, NOCD's sessions cost between $90 and $210, depending on the length of the visit.

The startup has raised about $85 million and says it expects to bring in more than $50 million in revenue this year.

NOCD has begun providing care for other mental-health conditions that can present alongside OCD, like tic disorders and hoarding disorders. Smith said NOCD plans to launch care for body-dysmorphic disorder in the next 12 months.

— Rebecca Torrence

Kathleen Sullivan, 37, is infusing healthcare research with the power of Microsoft's technology.

Sullivan is the senior director of strategy and operations in the health and life sciences division of Microsoft Research.

After leading strategy for a health plan and a pioneering digital-health startup, Sullivan wanted an even bigger arena. 

Sullivan joined Microsoft in 2017 to help the company's global research organization find its footing in healthcare.

As the senior director of strategy and operations within the health and life sciences division of Microsoft Research, Sullivan helps Microsoft decide where to place its bets in artificial intelligence, guided, for one, by the goal of directly helping patients.

That often looks like securing partnerships between Microsoft and other companies, helping researchers break up their big moonshot ideas into bite-sized milestones, and translating the value of Microsoft's health work to other areas of the company and to the industry at large. 

For example, Sullivan was part of the team that made the case for Microsoft to work with Nuance Technologies, known for making transcription tools for doctors. 

That partnership was a precursor to Microsoft's almost $20 billion acquisition of Nuance in 2021, a watershed moment for its healthcare push.

In 2018, Sullivan landed Microsoft's partnership with Adaptive Biotechnologies to map the human immune system. The deal included a $45 million Microsoft investment in the biotech company and other business terms that Sullivan helped negotiate. 

The companies have already discovered a type of blood test that has opened up new research avenues for vaccines, Sullivan said.

Now, as the healthcare industry races to work with Microsoft's latest AI models, Sullivan is even busier than usual, helping Microsoft decide where to go deep with partners, but also helping other companies understand what they can accomplish on their own with these powerful tools.

"To help evangelize a lot of the really incredible stuff we're doing is something I'm very proud of right now," she said.

— Blake Dodge

James Wong, 37, is helping people build their families.

Wong is the chief product officer at Carrot Fertility.
Carrot Fertility

Wong became homeless at 9 years old in New Zealand and bounced between foster homes in his teens, so he desperately wanted a family of his own. When he came out as gay at age 22, he was panic he could never have one.

Now, Wong and his husband are exploring having a child via a gestational surrogate — a path opened up to him by the growth of and innovations in the fertility industry, he said.

Wong joined the fertility-benefits startup Carrot Fertility at the beginning of 2021 and became the company's chief product officer a year later. He's helped build out Carrot's services beyond fertility care, including support for menopause, low testosterone, pregnancy, and postpartum care.

Trained as an engineer, Wong also oversees Carrot's efforts in data science and information security, as well as its global expansion. 

Central to Carrot's growth, he said, is leveraging clinical evidence to build Carrot's new offerings and collecting its own data to Strengthen the company's services. 

Carrot now works with more than 850 employers and health plans globally. More than 2 million people in over 130 countries can access the company's services with coverage through those employers.

Before coming to Carrot, Wong held product-management roles at companies including the genomics startup Genome Medical, the AI-powered life-sciences company Aktana, and the mental-health startup Lyra Health.

He's particularly excited about the future of precision medicine in fertility and in other areas like genomics and behavioral health and in using AI to connect each patient to the right provider or treatment for better outcomes.

"I think the best of precision care in these spaces has yet to come," he said.

— Rebecca Torrence

Alice Zhang, 34, is using AI and human data to come up with treatments for diseases more quickly.

Zhang is the CEO and cofounder of Verge Genomics.
Verge Genomics

Zhang is at the forefront of the biotech industry as the CEO and a cofounder of Verge Genomics, working on drugs for diseases that don't have good treatments, particularly ALS, Parkinson's, and Alzheimer's.

She's worked with machine learning and computational biology since her Ph.D. days and thought even then that "it's kind of crazy that people are still using things like mice to try to predict what will work in humans." 

It's not a crazy concept — using human data instead of animal models to identify effective human drugs. With AI advances across science and engineering, there's "potential to totally revolutionize how we discover drugs," she said. 

One way is through cutting the time it takes to develop certain drugs, which can take 10 years or more. Verge targeted and developed a potential ALS drug and is now testing it in people, all in the span of four years. The company has raised more than $134 million in funding.

"You can have as much data as you want and the fanciest algorithms but you're still not going to be able to predict something that actually works in humans," she said.

That's why Verge works with data derived from brains and spinal cords donated by people after they die. By generating the right clinical data, Zhang said they can feed it back into the company's AI to train and Strengthen it.

Beyond drugs, Zhang focuses on people and wants to show "there's a new way that people can work together that doesn't need to be ego-driven, that doesn't need to be fear-driven." She welcomes emotions in science because "emotions have a huge amount of data," and it's important to bring that to the table. 

—Josée Rose

Dr. Alice Zheng, 37, is backing the next generation of women's-health startups.

Zheng of RH Capital.
RH Capital

Zheng has spent her career focused on women's health — but the RH Capital investor took a roundabout route to the venture-capital world.

Zheng worked in reproductive health in Uganda and China before going to medical school at the University of Michigan. She took two years off from medical school to earn an MBA at Harvard, before returning to graduate. Then she dropped out of residency to join McKinsey, where she was the consulting firm's point person on women's health.

In 2021, Zheng realized she wanted to work with innovative women's-health companies more directly, and joined RH Capital as a principal.

She's since backed five women's-health startups, including the maternal-health startup Cayaba Care, the ovarian cancer diagnostics company AOA Dx, and the fertility startup Vitra Labs.

RH Capital is one of the larger funds focused solely on women's health, Zheng said, with about $40 million in assets under management. That's a relatively small figure in the world of venture capital, which highlights that women's health remains an emerging area of investment, Zheng noted. The sector has been growing steadily over the past few years, with $1.16 billion invested in women's-health startups in 2022, according to PitchBook.

The fund has remained active despite the economic downturn, Zheng said. She's interested in investing more in contraceptive innovations, life sciences companies working on maternal-health diagnostics, endometriosis treatments, and menopause care.

In addition to her work at RH Capital, Zheng mentors companies in the startup accelerator programs FemTechLab and Tech4Eva, and she regularly speaks at conferences and publishes articles about women's health.

"It's been amazing to see the conversation move from more targeted circles onto the main stage," she said.

—Rebecca Torrence

Thu, 17 Aug 2023 08:56:00 -0500 en-US text/html
Killexams : Protecting Competition or Preventing It? No result found, try new keyword!"If you can't reduce competition in the sense of harming rivals, you cannot engage in rivalry seeking to benefit consumers. " ~ Gary Galles ... Wed, 23 Aug 2023 02:00:00 -0500 en-us text/html Killexams : Microsoft News Roundup: ChatGPT at risk, Surface event confirmed, and Xbox community rules revamped No result found, try new keyword!Microsoft confirmed a Surface event and revamped its Xbox community guidelines this week. We also saw a report that OpenAI is marking toward bankruptcy. Here are the details on those stories and more ... Sat, 19 Aug 2023 23:33:11 -0500 en-us text/html Killexams : Washington among states that declined federal funds to find and replace dangerous lead pipes

As the Biden administration makes billions of dollars available to remove millions of dangerous lead pipes that can contaminate drinking water and damage brain development in children, some states are turning down funds.

Washington, Oregon, Maine and Alaska declined all or most of their federal funds in the first of five years that the mix of grants and loans is available, The Associated Press found. Some states are less prepared to pay for lead removal projects because, in many cases, the lead must first be found, experts said. And communities are hesitant to take out loans to search for their lead pipes.

States shouldn’t “shrug their shoulders” and pass up funds, said Erik Olson, a health and food expert at the environmental group Natural Resources Defense Council.

“It’s troubling that a state would decide to take a complete pass on the funding because part of the reason for the funding is to figure out whether you even have lead,” Olson said.

The Biden administration wants to remove all 9.2 million lead pipes carrying water to U.S. homes. Lead can lower IQ and create behavioral problems in children. The 2021 infrastructure law provides $15 billion to find and replace them. That money will help a lot, but it isn’t enough to get all the toxic pipes out of the ground. State programs distribute the federal funds to utilities.

The Environmental Protection Agency said it is reviewing state requests to decline funds but did not provide a full list of states that have said no so far. That information will be available in October, officials said. States that declined first-year funds can still accept them during the remaining four years.

“EPA has been working closely with our state partners on utilizing Bipartisan Infrastructure Law funding that is available,” the agency said.

Lead pipes are far more common in some states such as Michigan and Illinois, which each have hundreds of thousands. The harm there is clear. Flint’s lead crisis elevated lead in tap water to a national health issue. Residents of Benton Harbor, Michigan, drank water with too much lead for years until all their lead pipes were replaced. In response, however, Michigan is clamoring for as much money as it can get to remove lead.

The states that declined funds have fewer problematic pipes, but that doesn’t mean lead isn’t an issue. There’s concern about lead in some Maine schools. Portland, Oregon, has struggled with high lead levels for years, although exact tests have been better and officials say the issue isn’t lead pipes, but household plumbing.

Washington accepted $85,000 of $63 million it could have taken and said the decision was based on the limited number of water systems that wanted loans. The EPA estimates the state has 22,000 lead pipes. Oregon, which could have accepted $37 million, said inventories are going to be done with existing staff and resources, adding that utilities have no known lead lines. The EPA projected that the state has 3,530 lead pipes — a relatively small number — based in part on information collected from utilities.

The location of many lead pipes is a mystery. The EPA is requiring communities to provide initial inventories of their lead pipes by October 2024. Maine, which banned lead pipes far earlier than most states, said other funds would be used for inventories and they didn’t have lead replacement projects ready to fund. Most states that rejected funding initially indicated they would probably ask for money in later years.

To access the grants, there also needs to be demand for loans but utilities are hesitant to seek them out, according to Deirdre Finn, executive director of the Council of Infrastructure Financing Authorities, a group that represents the federally funded state programs that distribute infrastructure funds.

“This is a great opportunity,” Finn said. “But it would be helpful if states and utilities had access to 100% grant funding to move these projects along.”

Federal funds can only go to replacement projects that remove the entire lead pipe. Lead pipes run from the water main in the street to homes, but the ownership of the pipe is often split between the utility and homeowner. Some cities replace just the portion they own — a harmful practice that spikes lead levels — and paying to replace the homeowner’s side is often a problem. Grants can help utilities pay to replace the homeowner’s side, Finn said.

The EPA offered early funds based on a state’s general drinking water infrastructure needs — not the number of lead pipes. The EPA later developed estimates of each state’s lead pipes to inform how future years of funding should be distributed. Therefore, some states were offered more early money than they can spend.

In May, for example, Alaska told the EPA it wanted just $6.8 million of the $28 million it was entitled to receive. Carrie Bohan, facilities program manager in the division of water at the Alaska Department of Environmental Conservation, said utilities’ demand for loans to inventory their systems for lead pipes is “very, very small.” But over five years, there will be plenty of federal funds available to find the small number of lead pipes in Alaska and replace them.

Money that’s not used will be redistributed to other states that need it.

“I think it’s a potential disservice to other states if we were to apply for the full amount knowing that we couldn’t make use of it,” Bohan said.

But just figuring out how to distribute the money based on need is difficult. In April, the EPA’s lead pipe estimate surprised some experts by predicting that Florida had 1.16 million, the most of any state.

The higher estimate meant Florida would get more funds, but the state objected, arguing its utilities would find far more lead in the tap water if it really had that many lead pipes.

“Once these lead line surveys are completed, it is expected that the actual extent of facilities with lead service lines documented in Florida will be significantly less than what was estimated by the EPA,” said Brian Miller, a spokesperson with the Florida Department of Environmental Protection.


The Associated Press receives support from the Walton Family Foundation for coverage of water and environmental policy. The AP is solely responsible for all content. For all of AP’s environmental coverage, visit

Tue, 22 Aug 2023 09:06:00 -0500 en text/html
MS-500 exam dump and training guide direct download
Training Exams List